Panos Macheras is Emeritus Professor (obligatory retirement, 2014), Department of Pharmacy, University of Athens, Athens, Greece. 

B. Pharm. (1970), Ph.D. in Pharmaceutical Chemistry (1977), National and Kapodistrian University of Athens.

He also received a Ph.D. degree (1981) in Biopharmaceutics-Pharmacokinetics from King's College, University of London, U.K. Published more than 180 journal articles (6665 citations, h=40) and eight books in Biopharmaceutics-Pharmacokinetics. Research: experimental, theoretical and computational studies on dissolution, release, GI absorption, protein binding, drug-cyclodextrins interaction, bioequivalence, biopharmaceutic classification of drugs, pharmacokinetics, fractal and fractional kinetics, population pharmacokinetics and nonlinear dynamics.

Editorial Board member: Pharmaceutical Research, International Journal of Pharmaceutics and European Journal of Pharmaceutical Sciences.

HONORS, AWARDS

1. Visiting Associate Professor at the College of Pharmacy, University of Michigan (1988)
2. Founder (1991), Laboratory of Biopharmaceutics/Pharmacokinetics, National and Kapodistrian University of Athens
3. 1997-1998:  Vice president of Greek National Organization for Medicines.
4. Fellow, AAPS (1997)
5. Eurand Awards 2000, 2003: 27^th , 30^th CRS Annual meetings.
6. Fellow, American Institute for Medical and Biological Engineering ( 2007)
7. Doctor honoris causa, 2007, Carol Davila University of Bucharest, Romania.
8. 1998-2004/2005-2009 Member B15, group leader B25, European Cooperation in Science and Technology (COST).
9. Prize in Sciences (Academy of Athens): Book “P. Macheras, A. Iliadis.  Modeling in biopharmaceutics, PK/PD: homogeneous and heterogeneous approaches. Springer, 2006.
10. Listed among the top 25 contributing authors to Pharmaceutical Research (V. Lee, Pharm. Res. 25, 2007-12, (2008))
11. 2009: Advisor of the Greek AAPS student chapter; member of the AAPS i) International Affairs Committee and ii) Pediatric Initiative Committee.
12. Executive Committee member (2002-12): European Association of Faculties of Pharmacy
13. Voted second, Maurice-Marie Janot award (Malta, 2010).
14. Pharmaceutical Sciences World Congress Research Achievement Award (New Orleans,  2010).
15. January 10, 2010.The EMA Bioequivalence Guideline adopts the new bioequivalence limits  (References 114, 142 of CV).
16. Nationwide "2011 Xanthopoulos-Pneumatikos Award for Outstanding Academic Teaching"
17. 2014 Dale E. Wurster award in pharmaceutics, AAPS ,San Diego, CA
18. 2014-today: member of European Federation of Pharmaceuitcal Sciences (EUFEPS) Senate
19. “Commander of the Order of Honor” award by the Hellenic Republic, January 2015
20. Doctor honoris causa, Semmelweis University, Budapest, Hungary, November 2015
21. Consultant, Bill and Melinda Gates Foundation (2016)
22. Second edition of the book quoted in item 9 above. Springer- pp 483, 2016.
23. He established (July 2016) the Pharma-Informatics Unit of the Research and Innovation Center ATHENA
24. February 2018, Adjunct Professor, Department of Pharmaceutical Sciences, State University of New York, Buffalo, USA
25. September 2018, Expert member (FIP) International Pharmaceutical Federation, Board of Pharmaceutical Sciences
26.  Presidential Award from the European Federation of Pharmaceutical Sciences (EUFEPS) , 2018.
27. A special issue of the Journal of Pharmacokinetics and Pharmacodynamics (April 2019) was published "as a tribute to his contributions to science". (https://link.springer.com/journal/10928/46/2)
28. January 2023. Publication of  Springer book. P. Macheras, A. A. Tsekouras. Revising Oral Pharmacokinetics, Bioavailability and Bioequivalence Based on the Finite Absorption Time Concept, Springer, Cham.
29. January 2023. Establishment of Top Notch Pharma Company at Little Rock AR, USA. (www.topnotchpharma.com).
30. April 2023. Candidate, Editor in Chief AAPSJ.
31. May 2023. Nominated for the 2023 Distinguished scientist of the American Association Pharmaceutical Scientists award